 Westport, CT, May 04, 2021 GLOBE NEWSWIRE -- BioSig Technologies, Inc. NASDAQ: BSGM BioSig or the Company, a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it increased the patient case goal from 1000 to at least 1500 procedures by the end of 2021. 